Genetastix Corp., National Human Genome Center of Shanghai deal

Genetastix and the center's South Gene Technology Co. commercial arm formed Shanhai IgCon Therapeutics Co. Ltd., a joint venture that will focus on developing monoclonal antibodies. The JV, which will...